SCHEMBL30239581

SCHEMBL30239581

O=C(O)c1cc2c(Cl)ccnc2[nH]1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 1/20 0.46
NUDT1 P36639 6/20 0.46
DAO P14920 2/20 0.45
RHEB Q15382 3/20 0.44
AXL P30530 1/20 0.43
PRKCI P41743 1/20 0.43
F7 P08709 1/20 0.42
F3 P13726 1/20 0.42
EIF4A3 P38919 1/20 0.41
CDC7 O00311 1/20 0.40
PIM1 P11309 1/20 0.40
CDK9 P50750 1/20 0.40
IDO1 P14902 1/20 0.40
TDO2 P48775 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
LMNA P02545 1/20 0.40
CYP2C9 P11712 1/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20839678 1.00 GRIN1 (0.46) GRIN1NUDT1DAORHEBAXL
SCHEMBL23147720 0.87 NUDT1 (0.46) NUDT1DAOAXLPRKCICDC7
SCHEMBL20839895 0.85 NUDT1 (0.61) NUDT1DAORHEBAXLPRKCI
SCHEMBL30731013 0.85 NUDT1 (0.61) NUDT1DAORHEBAXLPRKCI
SCHEMBL20839976 0.83 NUDT1 (0.63) NUDT1DAOAXLPRKCIKMT2A
SCHEMBL899166 0.83 ABL1 (0.45) NUDT1DAOAXLPRKCI
SCHEMBL30226495 0.83 ABL1 (0.45) NUDT1DAOAXLPRKCI
SCHEMBL20839846 0.81 NUDT1 (0.64) NUDT1DAO
SCHEMBL7976646 0.81 DAO (0.45) NUDT1DAOF7F3IDO1
SCHEMBL3008612 0.80 IDO1 (0.49) NUDT1DAORHEBEIF4A3IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118401507-A Inhibitors targeting ubiquitin-specific protease 7 (USP 7) 丹娜法伯癌症研究院 2024-07-26 CN disclosed
EP-4373816-A1 INHIBITORS TARGETING UBIQUITIN SPECIFIC PROTEASE 7 (USP7) Dana-Farber Cancer Institute, Inc. (US) 2024-05-29 EP disclosed
WO-2023003973-A1 INHIBITORS TARGETING UBIQUITIN SPECIFIC PROTEASE 7 (USP7) DANA-FARBER CANCER INSTITUTE, INC. (US) 2023-01-26 WO disclosed